Category Archives: MS Treatment

Minister of State for Primary Care Alex White: said Biogen had told the HSE it intended to submit a revised application to the NCPE. Photograph: Alan Betson/The Irish Times The makers of a drug that helps people with multiple sclerosis to walk are to make a fresh application to have it covered by the Health Service Executive-funded drug schemes. People with MS, who say Fampridine (known commercially as Fampyra) has greatly increased their mobility, have criticised the HSE for not reimbursing the cost of the drug on the long-term illness scheme. In 2012, regulatory authorities concluded that Fampyra was not demonstrably cost-effective for the treatment of MS. The HSE said the manufacturers, Biogen Idec, had failed to demonstrate or provide any formal justification of the prices proposed, but did not rule out a revised application. The National Centre for Pharmaco-economics (NCPE), which rules on the cost-effectiveness of new drugs, said Fampyra would cost nearly 7,000 a patient each year. It said the 20 million annual cost to the State over five years would take money from other areas. Biogen later made the drug available free of charge to some patients as part of a late-stage clinical trial. Since Fampyra was … Continue reading →

June 7th, 2014 - in Atlanta, Ga. - MS Treatment Options, Adherence, Switching, etc. Jack S. Burks, MD June 7th, 2014 Atlanta, Ga. 30326 Treatment Options, Stem Cell Therapy, MS Relapse, Adherence, Compliance, Switching Meds, Symptom Manageme... By: MSViewsandNews … Continue reading →

Contact Information Available for logged-in reporters only Newswise Phoebe T. Ward, Jr. was the first patient to receive stereotactic radiosurgery at the University of New Mexico Cancer Center. The procedure killed the tumor in Ms. Wards brain by hitting it with x-rays. It took no more than 15 minutes but preparation for the procedure took months. Its a single treatment and theres no way to remove the radiation, says Eder Calderon. So we have physicists doing checks. We have the radiation therapists doing checks. We also include the radiation oncologist in some of those checks. Mr. Calderon is a medical physicist in the Department of Radiation Oncology at the UNM Cancer Center. He skillfully controls the ionizing radiation delivered to a person with cancer to noninvasively kill tumors, including brain tumors. He and the UNM Cancer Center medical physics team develop procedures to expand how they use the existing radiation equipment, giving people with cancer more options. Stereotactic radiosurgery is one of the new procedures theyve put in place; hippocampal-sparing radiation is another. Ms. Ward has received both. One precise dose Radiosurgery and radiation therapy kill cancer cells with radiation, but they require vastly different procedures. People receiving radiation therapy … Continue reading →

By Chris Smith Thursday 19 June 2014 Updated: 19/06 12:45 Buy photos Zoe Seville-Eden manager of the MS Centre (2nd left) with deputy Lord Mayor Mike Hammon and his consort Melanie Wood with users and friends of the centre celebrate its 30th anniversary. Picture by Jon Mullis 25.014.013.cov.jm2 (www.buyphotos247.com) A SMALL group of people with multiple sclerosis got together back in 1984 to raise money to buy an oxygen chamber to provide treatment for themselves and others with the condition. Fast forward 30 years and from those humble beginnings in Warwick via a small industrial unit in Binley, what is now known as the Mercia MS Therapy Centre in Aldermans Green is open six days a week and is used by around 80 people every week. The popularity of the hyperbaric oxygen chamber among MS sufferers and children with cerebral palsy, and later children with autism and people recovering from strokes, and an lottery grant funded the move to the current home which is also open to the public, offering physiotherapy, acupuncture, yoga, reflexology, massage, osteomyology, foot healthcare, art classes and social events. Deputy Lord Mayor Michael Hammond and Lord Digby Jones were guests of honour on Saturday as the … Continue reading →

CALGARY- Katie Gerke was just 24 when she was diagnosed with multiple sclerosis. I got off a stationary bike at the end of my workout, and my leg just gave out, Gerke recalls. At first her symptoms came and went, but like many patients with Relapsing Remitting MS, Gerkes disease progressed to a condition known as Secondary Progressive Multiple Sclerosis. With progressive MS, its a constant decline, so you dont really see that person getting better, you basically see that person gradually getting worse, Gerke explains from a wheelchair. She now lives in a long term care facility and is no longer able to use her arms and legs. According to Calgary MS researchers, there are few therapies available for patients with either primary or secondary progressive MS. We dont have a disease modifying treatment, so we dont have therapies that will slow down this progression, Dr. Marcus Koch explains. Koch hopes to help change that. The University of Calgary researcher is part of a multi-disciplinary team that plans to launch a new clinical trial involving progressive MS patients. The goal is to find out if drugs currently being used to treat other conditions like Parkinsons disease can be helpful … Continue reading →

MS treatment news story video of MS treatment in Russia. I don't own the copyright to this material, just want to share story with friends that have MS. Hopefully this will help them. By: marcusyalberto … Continue reading →

Danielle Letendre of Shelton has been named to receive a National MS Society, Connecticut Chapters 2014 Hayleys Hope and Michaelas Miracle MS Memorial Fund Scholarship. Danielle will enroll in a six-year health science program at Springfield College this fall. In addition to a roster full of AP courses and a four-year term on Shelton High Schools student council parliamentarian executive board, she was also a four-year member and three-year varsity letterman on both indoor and outdoor track and field. It was through this passion for sports that Letendre discovered her dream of becoming a physical therapist. After suffering a severe sports injury, which left doctors thinking she would never reach full mobility in her ankle again, Danielle was introduced to the world of physical therapy. After two months of physical therapy, I achieved the unattainable: my ankle had full rotation and I could sprint, said Letendre. I was so intrigued that I went on to intern at the same facility where I received my treatment. I learned so much from my time there and I cant wait to be on the other end of the recovery process by guiding someone through their challenges to reach their goals. Danielles greatest inspiration … Continue reading →

Denver, Colorado (PRWEB) June 08, 2014 DailyGossip.org publishes a complex review to a new method of curing multiple sclerosis. The Natural Multiple Sclerosis Treatment is described as a highly effective remedy for this serious condition. The new Natural Multiple Sclerosis Treatment review published by Daily Gossip Magazine indicates that the program was actually developed with the main purpose to offer an alternative to sufferers diagnosed with this condition. So, this is a natural MS cure method. To learn more about Dr Gary M Levin's latest natural treatment or download his new book read the full report at: http://www.dailygossip.org/natural-multiple-sclerosis-treatment-review-the-remarkable-ms-cure-7563 The author of this latest program describes MS as one of the most debilitating and discouraging conditions that can be diagnosed in any patient. The new method was created by Dr. Gary M. Levin, DailyGossip.org writes in its review. Levin claims that multiple sclerosis can increase the risk of developing many complications. The author of the Natural Multiple Sclerosis Treatment reveals that he worked for years with the main purpose to reach a unique combination of herbal remedies that can help in the cure of MS. Levin claims that he completely understood how multiple sclerosis evolves and how this condition is developed, … Continue reading →

Tupelo, MS (PRWEB) June 06, 2014 Dr. J. Michael Robertson, a leading periodontist in Tupelo, MS, offers his patients new hope for tooth replacement with a variety of dental implant options. Dr. Robertson also offers an alternative laser gum disease treatment for patients in need of gum surgery. The Laser Assisted New Attachment Procedure (LANAP) effectively treats gum disease and has the potential to save natural teeth that otherwise may be lost. LANAP is a revolutionary gum disease treatment. Minimally invasive, it is performed in much less time than other surgical gum treatments. Using a laser that targets bacteria and diseased tissue, Dr. Robertson can often complete treatment in one visit and most patients are back to work immediately. With the laser surgery patients usually experience less pain, less bleeding and less gum recession than with traditional gum surgery. Implants are generally recognized as the most desirable replacement for teeth and are widely preferred over traditional bridges and dentures. Dr. Robertson surgically places implants into the jaw bone for a secure tooth replacement as opposed to removable appliances that can slip and click. Fixed bridges can also create stress on the natural teeth they depend upon for structural support. Implants … Continue reading →

New treatment for MS is approved for use on NHS 10:00pm Thursday 5th June 2014 in News MULTIPLE sclerosis sufferers have been given a boost after a new treatment developed by an Oxford firm was approved to be available on the NHS. The National Institute for Health and Care Excellence (Nice) has sanctioned the use of Genzymes Lemtrada therapy to treat active relapsing remitting multiple sclerosis (RRMS), which accounts for 85 per cent of initial diagnoses of the disease. Brendan Martin, general manager for Genzyme UK and Ireland based at the Oxford Business Park, said: This final milestone brings a treatment option to people with MS that could really reshape the management of their condition. We are also immensely proud of our association with Lemtrada as a home-grown product, developed by a team of UK scientists. About 100,000 people in the UK have MS and about 2,500 people are diagnosed with it each year. Lemtrada is an antibody therapy which targets CD52, a protein thought to be responsible for the inflammatory process in MS. The treatment is the second of Genzymes treatments for MS to receive approval for NHS use. Our top stories: See the rest here: New treatment for … Continue reading →